Shanxi Province will adjust the maximum retail price of more than a thousand kinds of drugs

On the 25th, the reporter learned from the Shanxi Province Price Bureau that from March 28th onwards, Shanxi will adjust the maximum retail prices of some anti-microbial and cyclical medicines, and the types of drugs involved will involve more than a thousand species.

According to the notification issued by the Shanxi Provincial Price Bureau on the 25th to adjust some anti-microbial and cyclical medicines, Shanxi will reduce the maximum retail price of some anti-microbial and circulatory system drugs, involving 256 kinds of drugs that are separately priced, and uniformly pricing drugs. In 1294 species, 20 types of drugs were stipulated separately, and the separate pricing qualifications and prices of isosorbide mononitrate tablets manufactured by AstraZeneca were cancelled.

The notice stipulates that when major hospitals and pharmacies in Shanxi Province sell the above-mentioned drugs, the price must not exceed the maximum retail price announced this time; if the retail price for the centralized bidding and procurement of drugs is higher than the maximum retail price announced in the notice, the price shall be enforced according to this announcement; If the price is lower than the published price, the retail price of the winning bid medicine may not be increased.